165 related articles for article (PubMed ID: 34160449)
1. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
[TBL] [Abstract][Full Text] [Related]
2. Defibrotide for the treatment of veno-occlusive disease after liver transplantation.
Mor E; Pappo O; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R; Ben-Ari Z
Transplantation; 2001 Oct; 72(7):1237-40. PubMed ID: 11602848
[TBL] [Abstract][Full Text] [Related]
3. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.
Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Kitahara M; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Onishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
Transplant Proc; 2014 Dec; 46(10):3523-35. PubMed ID: 25498084
[TBL] [Abstract][Full Text] [Related]
4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Richardson PG; Murakami C; Jin Z; Warren D; Momtaz P; Hoppensteadt D; Elias AD; Antin JH; Soiffer R; Spitzer T; Avigan D; Bearman SI; Martin PL; Kurtzberg J; Vredenburgh J; Chen AR; Arai S; Vogelsang G; McDonald GB; Guinan EC
Blood; 2002 Dec; 100(13):4337-43. PubMed ID: 12393437
[TBL] [Abstract][Full Text] [Related]
7. Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.
Myers KC; Dandoy C; El-Bietar J; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Feb; 21(2):379-81. PubMed ID: 25300869
[TBL] [Abstract][Full Text] [Related]
8. The use of defibrotide in blood and marrow transplantation.
Richardson PG; Carreras E; Iacobelli M; Nejadnik B
Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.
Strouse C; Richardson P; Prentice G; Korman S; Hume R; Nejadnik B; Horowitz MM; Saber W
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1306-1312. PubMed ID: 27108694
[TBL] [Abstract][Full Text] [Related]
10. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
11. Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation.
Bagal B; Chandrasekharan A; Chougle A; Khattry N
Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):47-51. PubMed ID: 28460209
[TBL] [Abstract][Full Text] [Related]
12. Veno occlusive disease: update on clinical management.
Senzolo M; Germani G; Cholongitas E; Burra P; Burroughs AK
World J Gastroenterol; 2007 Aug; 13(29):3918-24. PubMed ID: 17663504
[TBL] [Abstract][Full Text] [Related]
13. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
Shah MS; Jeevangi NK; Joshi A; Khattry N
J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
[TBL] [Abstract][Full Text] [Related]
14. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening veno-occlusive disease after living-related liver transplantation.
Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
[TBL] [Abstract][Full Text] [Related]
16. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.
Ho VT; Linden E; Revta C; Richardson PG
Semin Thromb Hemost; 2007 Jun; 33(4):373-88. PubMed ID: 17525895
[TBL] [Abstract][Full Text] [Related]
17. Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.
Nauffal M; Kim HT; Richardson PG; Soiffer RJ; Antin JH; Cutler C; Nikiforow S; Gooptu M; Koreth J; Romee R; Ho VT
Blood Adv; 2022 Jan; 6(1):181-188. PubMed ID: 34666352
[TBL] [Abstract][Full Text] [Related]
18. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
19. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
20. Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease.
Mavrikou I; Chatzidimitriou D; Skoura L; Nikolousis E; Sakellari I; Gavriilaki E
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
